Cargando…
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19
ECMO management of severe ARDS patients with COVID-19, who are not responding to lung protective ventilation and salvage strategies like prone positioning or inhaled nitric oxide, is safe if performed in a dedicated referral centre. https://bit.ly/3p5HOEN
Autores principales: | Arikan, Huseyin, Cordingley, Jeremy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291956/ https://www.ncbi.nlm.nih.gov/pubmed/34295394 http://dx.doi.org/10.1183/20734735.0278-2020 |
Ejemplares similares
-
EOLIA trial: the future of extracorporeal membrane oxygenation in acute respiratory distress syndrome therapy?
por: Sameed, Muhammad, et al.
Publicado: (2019) -
Extracorporeal membrane oxygenation with right ventricular support in COVID-19 patients with severe acute respiratory distress syndrome
por: Tatooles, Antone J., et al.
Publicado: (2021) -
Successful application of extracorporeal membrane oxygenation due to pulmonary hemorrhage secondary to granulomatosis with polyangiitis
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2013) -
Acute respiratory distress syndrome in the cardiothoracic patient: State of the art and use of veno-venous extracorporeal membrane oxygenation
por: Copeland, Hannah, et al.
Publicado: (2021) -
Extracorporeal membrane oxygenation for acute respiratory distress syndrome
por: Aokage, Toshiyuki, et al.
Publicado: (2015)